Stockholders’ Equity and Stock-Based Compensation (Details) - Schedule of Activity for Common Stock Subject to Vesting |
12 Months Ended |
---|---|
Dec. 31, 2023
$ / shares
shares
| |
Share-Based Payment Arrangement [Abstract] | |
Shares subject to vesting, beginning balance | shares | 3,085,123 |
Weighted average grant date fair value, beginning balance | $ / shares | $ 5.01 |
Shares subject to vesting, ending balance | shares | 5,639,533 |
Weighted average grant date fair value, ending balance | $ / shares | $ 3.01 |
Shares subject to vesting, granted | shares | 5,081,863 |
Weighted average grant date fair value, granted | $ / shares | $ 2.08 |
Shares subject to vesting, vested | shares | (1,493,445) |
Weighted average grant date fair value, vested | $ / shares | $ 4.08 |
Shares subject to vesting, forfeited | shares | (1,034,008) |
Weighted average grant date fair value, forfeited | $ / shares | $ 2.92 |